Chemotherapy Plus Cetuximab versus Chemotherapy Alone for Patients with KRAS Wild Type Unresectable Liver-Confined Metastases Colorectal Cancer: An Updated Meta-Analysis of RCTs

Chemotherapy Plus Cetuximab versus Chemotherapy Alone for Patients with KRAS Wild Type Unresectable Liver-Confined Metastases Colorectal Cancer: An Updated Meta-Analysis of RCTs

Purpose. Our study analyses clinical trials and evaluates the efficacy of adding cetuximab in systematic chemotherapy for unresectable colorectal cancer liver-confined metastases patients. Materials and Methods. Search EMBASE, PubMed, and the Cochrane Central Register of Controlled Trials for RCTs c...

Full description

Saved in:

Bibliographic Details
Main Authors:	W. Lv, G. Q. Zhang, A. Jiao, B. C. Zhao, Y. Shi, B. M. Chen, J. L. Zhang
Format:	Article
Language:	English
Published:	Wiley 2017-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2017/8464905
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

[Comment] Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): a randomized controlled trial
by: Zhang Rongxin
Published: (2024-08-01)

[Comment] Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, openlabel, prospective, randomised controlled trial
by: Zhang Rongxin
Published: (2024-12-01)

No survival benefit from adding cetuximab or panitumumab to oxaliplatin-based chemotherapy in the first-line treatment of metastatic colorectal cancer in KRAS wild type patients: a meta-analysis.
by: Si-wei Zhou, et al.
Published: (2012-01-01)

Anlotinib plus chemotherapy as a first-line treatment for gastrointestinal cancer patients with unresectable liver metastases: a multicohort, multicenter, exploratory trial
by: Jun-Wei Wu, et al.
Published: (2024-12-01)

Preoperative chemotherapy plus immune checkpoint inhibitors as conversion therapy in pancreatic cancer patients with initially unresectable liver-limited metastases: a case report
by: Li Xiao, et al.
Published: (2025-06-01)

Excellent response of cetuximab plus chemotherapy after pembrolizumab monotherapy in metastatic hypopharyngeal cancer: A case report
by: Anh Tuan Pham, et al.
Published: (2025-03-01)

Hepatic arterial infusion chemotherapy (HAIC) plus Lenvatinib and PD-1 inhibitors versus systemic chemotherapy for unresectable intrahepatic cholangiocarcinoma
by: Qingyu Xu, et al.
Published: (2025-05-01)

Cost-effectiveness analysis of anlotinib plus chemotherapy with or without benmelstobart versus chemotherapy alone for extensive-stage small-cell lung cancer in China
by: Caicong You, et al.
Published: (2024-12-01)

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Chinese patients with advanced non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials
by: Jianfei Zhang, et al.
Published: (2025-07-01)

Pneumatosis Cystoides Intestinalis after Cetuximab Chemotherapy for Squamous Cell Carcinoma of Parotid Gland
by: Christos Petrides, et al.
Published: (2015-01-01)

First-line treatment with durvalumab plus chemotherapy versus chemotherapy alone for metastatic non-small-cell lung cancer in the USA: a cost-effectiveness analysis
by: Ling Fang, et al.
Published: (2023-12-01)

Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canal
by: Amit Joshi, et al.
Published: (2015-01-01)

Successful radical surgical resection of initially unresectable intrahepatic cholangiocarcinoma by downsizing chemotherapy with gemcitabine plus cisplatin: a case report
by: Ryosuke Takayanagi, et al.
Published: (2017-11-01)

Immune checkpoint inhibitors plus chemotherapy in the first-line treatment of young unresectable gastric cancer patients: a multicentre real-world study
by: Yingnan Wang, et al.
Published: (2025-04-01)

Corneal Perforation during Combination Chemotherapy including Cetuximab in a Patient with a History of Herpetic Keratitis
by: Keiichi Aomatsu, et al.
Published: (2020-01-01)

Atezolizumab plus bevacizumab and chemotherapy versus bevacizumab plus chemotherapy for metastatic cervical cancer: a cost-effectiveness analysis
by: Hongfu Cai, et al.
Published: (2024-10-01)

Excellent response to oral Metronomic chemotherapy in unresectable adenocarcinoma of external auditory canal
by: Vanita Noronha, et al.
Published: (2015-01-01)

Chemotherapy with cetuximab in head and neck squamous cell carcinoma: immunological aspects and markers of treatment effectiveness in clinical practice
by: A. I. Stukan, et al.
Published: (2024-06-01)

Survival in patients with unresectable hepatocellular carcinoma: TCC cocktail plus TACE vs TACE alone prospective randomized clinical trial
by: Jie Li, et al.
Published: (2025-07-01)

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone as the first line treatment for advanced biliary tract cancer: a pooled analysis of KEYNOTE-966 and TOPAZ-1 trails
by: Jiashou Wang, et al.
Published: (2025-06-01)

PD‐1/PD‐L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First‐Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study
by: Riqing Huang, et al.
Published: (2025-03-01)

Response and relapses in pediatric Hodgkin's Lymphoma treated with chemotherapy alone
by: Vineeta Gupta, et al.
Published: (2019-01-01)

Comparative efficacy and safety of anti-HGF/MET pathway agents plus chemotherapy versus chemotherapy alone as first-line treatment in advanced gastric cancer: a protocol for a systematic review and meta-analysis
by: Chunyu Liu, et al.
Published: (2021-12-01)

Update on Intra-Arterial Chemotherapy for Retinoblastoma
by: Mario Zanaty, et al.
Published: (2014-01-01)

Advances in hepatic arterial perfusion chemotherapy for hepatic metastases
by: Haodi Ou, et al.
Published: (2025-06-01)

SOX chemotherapy is effective for gastric cancer with liver metastases
by: Cong Wang, et al.
Published: (2025-05-01)

Promising Response to Neoadjuvant Chemotherapy Plus Immunotherapy in Metaplastic Breast Carcinoma
by: Tan Q, et al.
Published: (2025-05-01)

First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial
by: Yuankai Shi, et al.
Published: (2025-05-01)

Efficacy and safety of immunotherapy combined with chemotherapy in patients with ES‐SCLC: A systematic review and network meta‐analysis of RCTs and RWSs
by: Runting Kang, et al.
Published: (2024-11-01)

Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas
by: Tiffany A. Pompa, et al.
Published: (2017-01-01)

Liver Transplantation for Unresectable Colorectal Liver Metastases
by: Yash Kadakia MD, et al.
Published: (2025-07-01)

The impact of combining cetuximab with the traditional chemotherapy regimens on clinical effectiveness in metastatic colorectal cancer: a systematic review and meta-analysis
by: Marryam Azeem, et al.
Published: (2025-02-01)

Hepatic arterial infusion chemotherapy plus regorafenib compared with regorafenib alone as second-line therapy for advanced hepatocellular carcinoma: a randomised controlled trial protocol
by: Wei Sun, et al.
Published: (2024-12-01)

Comparing internal jugular vein and subclavian vein for central venous insertion of implantable ports in cancer chemotherapy: a meta-analysis of RCTs
by: Qianqian Li, et al.
Published: (2025-05-01)

Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma
by: Wen-Chen Tang, et al.
Published: (2023-07-01)

KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma
by: Analia Meilerman Abuelafia, et al.
Published: (2025-07-01)

Successful conversion surgery for gastric cancer with multiple liver metastases treated after S-1 plus cisplatin combination chemotherapy: a case report
by: Masashi Tsunematsu, et al.
Published: (2017-08-01)

Immunomodulatory effects in a phase II study of lenalidomide combined with cetuximab in refractory KRAS-mutant metastatic colorectal cancer patients.
by: Anita K Gandhi, et al.
Published: (2013-01-01)

Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab
by: Toshihiko Matsumoto, et al.
Published: (2025-08-01)

Efficacy and factors related to prognosis of combination chemotherapy with different radiotherapy methods in patients with unresectable hepatocellular carcinoma
by: Lian-Qiang Han
Published: (2025-04-01)